Influence of valve replacement on plasma endothelin-1 level in mitral stenosis

Journal of Heart Valve Disease

Volumn 9, Issue 1, 2000, Pages 82-87

  Snopek, Grazyna ^a,b   Pogorzelska, Hanna ^a   Korewicki, Jerzy ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

^b NONE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1;

ADULT; ARTICLE; BLOOD LEVEL; CATHETERIZATION; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODYNAMICS; HUMAN; LUNG ARTERY PRESSURE; LUNG CIRCULATION; MALE; MITRAL VALVE REPLACEMENT; MITRAL VALVE STENOSIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; EXERCISE TOLERANCE; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; MITRAL VALVE; MITRAL VALVE STENOSIS; PROSPECTIVE STUDIES;

EID: 0033970241     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Loscalzo J. Endothelial dysfunction in pulmonary hypertension. N Engl J Med 1992;327:117-119
2. Giaid A. Nitric oxide and endothelin-1 in pulmonary hypertension. Chest 1998;114(Suppl.3): 208S-212S
3. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415
4. Dubin D, Pratt RE, Dzau VJ. Endothelin, a potent vasoconstrictor is a vascular smooth muscle mitogen. J Vas Med Biol 1989;1:150-154
5. Wood P. Pulmonary hypertension with special reference to the vasoconstrictive factor. Br Med J 1958;20:557-570
6. Wangenvoort C, Wangenvoort N. Pathology of pulmonary hypertension. John Wiley & Sons, New York 1977:177-216
7. Pogorzelska H, Korewicki J, Zielinski T, Rajecka A, Biederman A. Prognostic significance of changes in the compliance venous system after isosorbiddinitrate in patients with mitral stenosis. Int J Cardiol. 1994;49:9-15
8. Korewicki J, Pogorzelska H, Zielinski T, Rajecka A. Influence of isosorbiddinitrate on compliance of the pulmonary venous system. J Heart Valve Dis 1993;2:200-205
9. Engelberg J, Dubois A. Mechanics of pulmonary circulation in isolated rabbit lungs. Am J Physiol 1959,196:401-414
10. Pogorzelska H., Korewicki J. The role of endothelin-1 and pulmonary arterial compliance in patients with secondary pulmonary hypertension. Curr Pneumonol 1999;3:19-23
11. Stewart DJ, Levy RD, Cernacek P, Langleben D. Increased plasma endothelin-1 in pulmonary hypertension - marker or mediator of disease? Ann Intern Med 1991;114:464-469
12. Vincent JA, Ross RD, Kassab J, Hsu J, Pinsky WW. Relation of elevated plasma endothelin in congenital heart disease to increased pulmonary flow. Am J Cardiol 1993;71:1204-1207
13. Cacoub P, Dorent R, Maistre G, et al. Endothelin-1 in primary pulmonary hypertension and the Eisenmenger syndrome. Am J Cardiol 1993;71:448-450
14. Nootens M, Kaufman E, Rector T, et al. Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension. J Am Coll Cardiol 1995;26:1581-1585
15. Pacher R, Klein JB, Globits, S et al. Plasma endothelin-1 concentrations in congestive heart failure in patients with or without systemic hypertension. Am J Cardiol 1993;71:1293-1299
16. McMurray JJ, Ray SC, Abdullah I, Dargie H, Morton JJ. Plasma endothelin in chronic heart failure. Circulation,1992;85:1374-1379
17. Cody RJ, Haas GJ, Binkley PF, Capers Q, Kelley R. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic heart failure. Circulation 1992;85:504-509
18. Cacoub P, Dorent R, Nataf P, et al. Endothelin-1 in the lungs of patients with pulmonary hypertension. Cardiovasc Res 1997;33:196-200
19. Stewart DJ, Cercacek P, Costello K, Rouleau JJ. Elevated endothelin-1 in heart failure and loss of normal response to postural change. Circulation 1992;85:510-517
20. Cacoub P, Dorent R, Nataf P, et al. Plasma endothelin and pulmonary pressures in patients with congestive heart failure. Am Heart J 1993;126:1484-1488
21. Pousset F, Isnard R, Lechat P, et al. Prognostic value of plasma endothelin in patients with chronic heart failure. Eur Heart J 1997;18:254-258
22. Monge JC. Neurohormonal markers of clinical outcome in cardiovascular disease: Is endothelin the best one? J Cardiovasc Pharmacol 1998;32(Suppl.2): S36-S42
23. Stewart DJ, Cernacek P, Glosselin G. Human pulmonary circulation is an important site for both clearance and production of endothelin-1. Circulation 1996;94:1578-1584
24. Tsumamoto T, Wada A, Maeda Y, Adachi T, Kinoshita M. Relation between endothelin spillover in the lungs and pulmonary vascular resistance in patients with chronic heart failure. J Am Coll Cardiol 1994;23:1427-1433
25. Giaid A, Yanagisawa M, Langleben D, et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 1993;328:1739-1744
26. Dupuis J, Cernacek P, Tardiff J-C, et al. Reduced pulmonary clearance of endothelin-1 in pulmonary hypertension. Am Heart J 1998;135:614-620
27. Ozaki S, Ohwaki K, Ihara M, Fukuroda T, Ishikawa K, Yano M. ET B mediated regulation of extracellular levels of endothelin-1 in cultured human endothelial cells. Biochem Biophys Res Commun 1995;209:483-489
28. Yamamoto K, Ikeda U, Mito H, Fujikawa H, Sekiguchi H, Shimada K. Endothelin production in pulmonary circulation of patients with mitral stenosis. Circulation 1994;89:2093-2098
29. Stewart DJ. Endothelin in cardiopulmonary disease: Factor paracrine vs neurohormonal. Eur Heart J 1993;14(Suppl.I):S48-S54
30. Kiowski W, Sutsch G, Hunziker P, et al. Evidence for endothelin-1 mediated vasoconstriction in severe chronic heart failure. Lancet 1995;346:732-736
31. Zamora M, Stelzner TJ, Webb S Panos RJ, Ruff L, Dempsey EC. Overexpression of endothelin-1 and enhanced growth of pulmonary artery smooth muscle cells from fawn-hooded rats. Am J Physiol 1996;14:L101-L109
32. Miyauchi T, Yorikane R, Sakai S. Contribution of endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ Res 1993;73:887-897
33. Sakai S, Miyauchi T, Sakurai T, et al. Pulmonary hypertension caused by congestive heart failure is ameliorated by long-term application of endothelin receptor antagonist. J Am Coll Cardiol 1996;28:1580-1588
34. Hang Chang, Gong-Jhe Wu, Shih-Ming Wang, Chi-Ren Hung. Plasma endothelin levels and surgically correctable pulmonary hypertension. Ann Thorac Surg 1994;55:450-458
35. Webb DJ, Strachan FE. Clinical experience with endothelin antagonists. AJH 1998;11:71S-75S